Efficacy and Safety of Hydroxyurea in the Treatment of Sickle Cell Anemia Children in Jos, North Central Nigeria

被引：1
|
作者：
Ofakunrin, Akinyemi Olugbenga David [1 ]
Adekola, Kehinde U. [2 ]
Oguche, Stephen [3 ]
Okpe, Edache Sylvanus [3 ]
Sagay, Atiene Solomon [4 ]
机构：
[1] Univ Jos, Dept Paediat, Jos, Nigeria
[2] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[3] Univ Jos, Jos Univ Teaching Hosp, Dept Paediat, Jos, Nigeria
[4] Univ Jos, Jos Univ Teaching Hosp, Dept Obstet & Gynaecol, Jos, Nigeria
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-115598
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1081
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central Nigeria
    Ofakunrin, Akinyemi O. D.
    Oguche, Stephen
    Adekola, Kehinde
    Okpe, Edache S.
    Afolaranmi, Tolulope O.
    Diaku-Akinwumi, Ijeoma N.
    Zoakah, Ayuba, I
    Sagay, Atiene S.
    JOURNAL OF TROPICAL PEDIATRICS, 2020, 66 (03) : 290 - 298
  • [2] Hydroxyurea treatment in patients affected with sickle cell anemia: Efficacy and safety
    de Montalembert, M.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2008, 15 (1-2) : 34 - 38
  • [3] Hydroxyurea treatment in children with sickle cell anemia in Central America and the Caribbean countries
    Svarch, Eva
    Nieves, Rosa Maria
    Mancia de Reyes, Ana Gladys
    Navarrete, Marta
    Rodriguez, Hilze
    PEDIATRIC BLOOD & CANCER, 2006, 47 (01) : 111 - 112
  • [4] Level of utilization and provider-related barriers to the use of hydroxyurea in the treatment of sickle cell disease patients in Jos, North-Central Nigeria
    Ofakunrin, Akinyemi O. D.
    Okpe, Edache S.
    Afolaranmi, Tolulope O.
    Olaosebikan, Rasaq R.
    Kanhu, Patience U.
    Adekola, Kehinde
    Dami, Nantok
    Sagay, Atiene S.
    AFRICAN HEALTH SCIENCES, 2021, 21 (02) : 765 - 774
  • [5] Hydroxyurea for the treatment of sickle cell anemia
    Platt, Orah S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (13): : 1362 - 1369
  • [6] Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia
    Rankine-Mullings, Angela
    Keenan, Russell
    Chakravorty, Subarna
    Inusa, Baba
    Telfer, Paul
    Velangi, Mark
    Ware, Russell E.
    Moss, Jon J.
    Lloyd, Adam L.
    Edwards, Sarah
    Mulla, Hussain
    BLOOD ADVANCES, 2023, 7 (16) : 4319 - 4322
  • [7] Hydroxyurea Treatment of Young Children with Sickle Cell Anemia: Safety and Efficacy of Continued Treatment - the BABY HUG Follow-up Study
    Rogers, Zora R.
    Fish, Billie
    Luo, Zhaoyu
    Iyer, Rathi V.
    Thornburg, Courtney D.
    Sarnaik, Sharada A.
    Rana, Sohail R.
    Luchtman-Jones, Lori
    Jackson, Sherron M.
    Howard, Thomas H.
    Casella, James F.
    Brown, R. Clark
    Alvarez, Ofelia A.
    Goldsmith, Jonathan C.
    Miller, Scott T.
    Wang, Winfred C.
    BLOOD, 2011, 118 (21) : 9 - 9
  • [8] Hydroxyurea pharmacokinetics in children with sickle cell anemia
    Harrod, Virginia L.
    Sparreboom, Alex
    Nicole, Mortier
    Susan, Strawn
    Howard, Thad
    Ware, Russell E.
    PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 613 - 613
  • [9] Hydroxyurea in children with Sickle cell anemia, should it be a life long treatment?
    El Alfy, MS
    BLOOD, 2000, 96 (11) : 16B - 16B
  • [10] Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia
    Aygun, Banu
    Mortier, Nicole A.
    Smeltzer, Matthew P.
    Shulkin, Barry L.
    Hankins, Jane S.
    Ware, Russell E.
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (02) : 116 - 119
12345